EMA’s human medicines committee (CHMP) has started a phased review of data on daraxonrasib, a medicine intended for the treatment of metastatic pancreatic cancer. A phased…
Source: European Medicines Agency — News
You may also like
Ebola Outbreak Could Cost Africa Up to $3.6bn, UN Warns
DR Congo Ebola Outbreak Becomes Third-Largest on...
DR Congo Ebola Cases Rise to 1,406; Deaths Reach 438
WHO Declares Hantavirus Outbreak Over, Thanks Spain...
WHO adds first diagnostic test for Ebola Bundibugyo...
Patient enrolment begins in a scientific trial to...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.